Robeco Institutional Asset Management B.V.
Position in AMPH — Amphastar Pharmaceuticals, Inc.
CIK 1418773
ROTTERDAM, P7
Position in AMPH
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$1,340,093
+$39,180 QoQ
Shares Held
66,407
0.0% QoQ
Ownership
0.156%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 209 holders
Holding Since
Mar 2022
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMPH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Robeco Institutional Asset Management B.V. holds $403,524,623 across 13 Drug Manufacturers - Specialty & Generic names. AMPH ranks #11 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
|
18,021,100 | $261,125,739 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
123,056 | $66,675,432 | |
| 3 | VTRS |
Viatris Inc
|
2,080,468 | $33,037,831 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
107,976 | $18,198,275 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
128,116 | $5,256,599 | |
| 6 | ALKS |
Alkermes plc.
|
92,592 | $4,851,357 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
174,003 | $4,282,213 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
164,014 | $4,161,035 |
All Filings in AMPH
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,340,093 | 66,407 | Shares | Defined | 2026-07-21 | |
| 2026-03-31 | $1,300,913 | 66,407 | Shares | Defined | 2026-04-21 | |
| 2022-09-30 | $1,025,565 | 36,497 | Shares | Defined | 2022-12-01 | |
| 2022-06-30 | $1,269,730 | 36,497 | Shares | Defined | 2022-12-01 | |
| 2022-03-31 | $1,204,839 | 33,561 | Shares | Defined | 2022-12-01 | |
| No filing history on record for this holder in this stock. | ||||||